Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01372878 · ClinicalTrials.gov registry record · NA
Evaluation of Capsule Endoscopy With PillCam® COLON 2 in Visualization of the Colon
A NA study of CRC Screening, sponsored by Medtronic - MITG.
- Completed
- Registry status
- NA
- Development phase
- 884
- Enrollment target
- 17
- Study locations
NCT01372878: Completed NA study of CRC Screening, sponsored by Medtronic - MITG.
NCT01372878 is a NA study of CRC Screening that has completed, run by Medtronic - MITG. The registered enrollment target is 884 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (37% lower). The trial reports 17 study locations across 11 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01372878, a NA study of CRC Screening, has completed, sponsored by Medtronic - MITG.
- COMPLETED
- Registry status
- NA
- Development phase
- 884 participants
- Enrollment target
- 17
- Study locations
Study Summary
This study was design to establish the effectiveness of PillCam® Platform with the PillCam® COLON 2 capsule as demonstrated by the identification of subjects with polyps as compared to optical colonoscopy.
Primary Outcome
Sensitivity and specificity of PillCam Platform with the PillCam COLON 2 capsule in detecting subjects with polyps equal to or larger than 6 mm. For a given polyp, a match between the PillCam Colon 2 Capsule and optical colonoscopy was considered if the polyp size was assessed within plus or minus 50% of the size of the estimate of the OC measurement and the polyp as appearing within the same colon segment or in adjacent segments. The polyp size measurement by optical colonoscopy was used as the
Conditions Studied
Interventions
- PROCEDURE Colonoscopy
- DEVICE PillCam® COLON 2 procedure
Study Locations (17)
Other
- Soroka University Medical Center - Beersheba
- Rambam Medical Center - Haifa
- Bikur Holim Hospital - Jerusalem
- Rabin Medical Center - Petah Tikva
- The Tel-Aviv Sourasky Medical Center - Tel Aviv
- The Chaim Sheba Medical Center at Tel-Hashomer - Tel Litwinsky
Texas
- Gastroenterology Consultants, P.A. - Houston
- Pasadena Gastroenterology Associates, P.A. - Pasadena
Alabama
- Alabama Digestive Disorders Center P.C. - Huntsville
Indiana
- Indiana University Hospital - Indianapolis
Kentucky
- Louisville Gastroenterology Associates - Louisville
Missouri
- Specialists in Gastroenterology - St Louis
New York
- Research Associates of New York - New York
North Carolina
- UNC Chapel Hill Gastroenterology and Hepatology - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 884 participants |
| Start Date | 2011-06 |
| Est. Completion | 2012-06 |
| Phase | NA |
What the finished NCT01372878 record still lists
NCT01372878 is an interventional study that assigns participants to a tested intervention. The registered 884 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (37% lower).
The record links to 1 condition, with CRC Screening appearing as the primary indexed condition, and to 2 interventions - of which Colonoscopy is the first listed.
NCT01372878 lists 17 locations in 11 states (Other, Texas, Alabama).
Frequently Asked Questions
What is clinical trial NCT01372878 about?
NCT01372878 is a clinical study titled "Evaluation of Capsule Endoscopy With PillCam® COLON 2 in Visualization of the Colon". This study was design to establish the effectiveness of PillCam® Platform with the PillCam® COLON 2 capsule as demonstrated by the identification of subjects with polyps as compared to optical colonoscopy.
What is the current status of trial NCT01372878?
This trial is currently completed. It is a NA study. The enrollment target is 884 participants. The study started on 2011-06. Estimated completion is 2012-06.
What conditions does trial NCT01372878 study?
This clinical trial studies the following conditions: CRC Screening.
What interventions are being tested in trial NCT01372878?
The interventions under investigation include: Colonoscopy (PROCEDURE), PillCam® COLON 2 procedure (DEVICE).
Who is sponsoring clinical trial NCT01372878?
This trial is sponsored by Medtronic - MITG, which has 119 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01372878 being conducted?
This trial has 17 study locations across Alabama, Indiana, Kentucky, Missouri, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for CRC Screening
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01372878's enrollment target sits among peer trials
884 130th of 2000 higher than 1,871 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07196748 · 882 participants · Phase 3
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
- NCT05174286 · 880 participants · NA
Community Health Workers United to Reduce Colorectal Cancer and Cardiovascular Disease Among People at Higher Risk
- NCT05454280 · 880 participants · Phase 3
Post-Discharge Risk-Based Management in Patients Undergoing High-Risk Elective Major Cancer Operations (PRS II)
- NCT05525663 · 880 participants · NA
Physical Rehabilitation for Older Patients With Acute Heart Failure With Preserved Ejection Fraction
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia